Chronic News and Research

RSS

Poor sleep before surgery linked to increased risk of postoperative delirium

People who experience poor sleep in the month before surgery may be more likely to develop postoperative delirium, according to new research being presented at the ANESTHESIOLOGY® 2024 annual meeting.

20 Oct 2024

New tool helps identify anxiety and depression in pediatric surgery patients

A new, computerized, mental health assessment tool may allow doctors to quickly identify children experiencing anxiety or depression before surgery, suggests new research presented at the ANESTHESIOLOGY® 2024 annual meeting.

20 Oct 2024

Study suggests NSAIDs may lower postoperative delirium risk

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may help reduce patients' risk of postoperative delirium, according to a study presented at the ANESTHESIOLOGY® 2024 annual meeting.

20 Oct 2024

Blood test predicts preeclampsia risk in laboring women

A simple blood test could help doctors identify women in labor who are at risk for preeclampsia - a leading cause of maternal death - and take precautions to prevent it, according to research presented at the ANESTHESIOLOGY 2024 annual meeting.

20 Oct 2024

Repeated fasting for multiple orthopedic surgeries linked to poor recovery outcomes

People who have multiple orthopedic surgeries during the same hospital stay are more likely to suffer malnutrition due to repeated or prolonged fasting, which can slow recovery and increase the risk of death, according to a study of more than 28 million patients presented at the ANESTHESIOLOGY 2024 annual meeting.

20 Oct 2024

Long-term low-dose antiviral treatment reduces eye disease risk from shingles

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new research presented October 19 at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.

20 Oct 2024

Cleveland Clinic integrates AI-powered platform to enhance digestive disease care

To expand access to care for patients, Cleveland Clinic has added Ayble Health, an AI-enabled digital care platform, to its multidisciplinary care model for the treatment of chronic digestive diseases.

20 Oct 2024

Kumamoto University makes groundbreaking discovery in aging and inflammation

A team at Kumamoto University has made a groundbreaking discovery in the field of aging and inflammation. Japan's aging population is growing at an unprecedented rate, making it crucial to extend healthy lifespans rather than just lifespans.

20 Oct 2024

Revolutionizing precision nutrition with gut microbiome insights

Researchers at Rutgers University-New Brunswick, along with international collaborators, have introduced a novel method for identifying the crucial set of gut microbes commonly found in humans and essential for health.

18 Oct 2024

Sciensus names Christian Tucat as Chief Executive Officer

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

From Sciensus 18 Oct 2024

Understanding cardiovascular risks in endometriosis patients

Endometriosis increases the risk of cardiovascular events.

18 Oct 2024

Mountain town confronts an unexpected public health catastrophe

Before Hurricane Helene, had you stopped by one of the many breweries, art galleries, or award-winning restaurants in Asheville, North Carolina, and spoken with anyone who lives in these parts — including me — most would have told you they felt pretty safe from climate disasters.

18 Oct 2024

New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering hypoglycemia risk

NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, reducing hypoglycemia in diabetes care.

18 Oct 2024

Study finds oral contraceptives may alter glycemic response in women using androgenic pills

This research highlights the metabolic effects of androgenic contraceptives, showing significant increases in postprandial glucose and insulin levels in women.

18 Oct 2024

Ubiquigent partners with Alleo Labs to advance DUB-targeting therapies

Ubiquigent Limited (“Ubiquigent”), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced a strategic partnership with Alleo Labs Corp. (“Alleo”), a pioneer in using artificial intelligence (AI) to develop new therapeutics for neurological diseases.

18 Oct 2024

New study reveals two-thirds of diabetic men suffer from erectile dysfunction

Erectile dysfunction (ED) affects up to 66% of diabetic men globally, with risk factors like age, long-term diabetes, and obesity playing a significant role. The study emphasizes the urgent need for early diagnosis and effective diabetes management to reduce the burden of ED

17 Oct 2024